| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/20/2005 | US20050234001 Methods and compositions for modulating gluconeogenesis using PGC-1 |
| 10/20/2005 | US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 10/20/2005 | US20050233995 Immunostimulatory nucleic acid molecules |
| 10/20/2005 | US20050233990 Anti-cancer agents comprising disintegrin genes and the treating methods |
| 10/20/2005 | US20050233972 Neuropeptides and their use for pest control |
| 10/20/2005 | US20050233969 Analogues of GLP-1 |
| 10/20/2005 | US20050233964 Chimeric VEGF peptides |
| 10/20/2005 | US20050233963 Heat shock response and virus replication |
| 10/20/2005 | US20050233960 Methods and compositions for inhibiting c-met dimerization and activation |
| 10/20/2005 | US20050233959 Use of MDA-7 to inhibit pathogenic infectious organisms |
| 10/20/2005 | US20050233958 Using tumor necrosis factor receptor to identify modulators for prevention and treatment of cell proliferative disorders |
| 10/20/2005 | US20050233957 Sodium channel regulators and modulators |
| 10/20/2005 | US20050233952 Peptide structure containing lanthionine and methyllanthionine as constituents isolated from Microbispora sp. ATCC PTA-5024; methicillin resistant and vancomycin resistant bacteria; M. catharralis, Neisseria species and H. influenzae and Mycobacteria |
| 10/20/2005 | US20050233458 Novel expansin polynucleotides, related polypeptides and methods of use |
| 10/20/2005 | US20050233435 Plasmodium axenic liver stages as a noninfectious whole organism malaria vaccine |
| 10/20/2005 | US20050233418 Cytokine polypeptides |
| 10/20/2005 | US20050233417 Growth hormone variations in humans and their uses |
| 10/20/2005 | US20050233413 Neuroprotective polypeptides and methods of use |
| 10/20/2005 | US20050233412 An artificial mutant tRNA synthetase; aminoacylates an orthogonal tRNA with beta -GlcNAc-serine |
| 10/20/2005 | US20050233411 Compositions and methods for cleaving IAP |
| 10/20/2005 | US20050233408 Modified bacterial surface layer proteins |
| 10/20/2005 | US20050233391 modulating expression of NKG2D in a lymphocyte capable of expressing NKG2D comprising binding a tumor cell produced MIC polypeptide with a monoclonal antibody; biomarker |
| 10/20/2005 | US20050233386 Human hematopoietic growth regulatory gene and uses |
| 10/20/2005 | US20050233385 Using antibodies on cell surfaces |
| 10/20/2005 | US20050233383 Human olfactory receptors and genes encoding same |
| 10/20/2005 | US20050233379 Methods of antagonizing morphogens |
| 10/20/2005 | US20050233374 Reagents and methods useful for detecting diseases of the prostate |
| 10/20/2005 | US20050233372 Use of SNPs of MCH-R for identifying genetic disorders in maintaining the normal body weight |
| 10/20/2005 | US20050233371 CNG2B: a novel human cyclic nucleotide-gated ion channel |
| 10/20/2005 | US20050233361 PPARdelta assay |
| 10/20/2005 | US20050233359 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 10/20/2005 | US20050233350 Method for typing of minor histocompatibility antigen HA-1 |
| 10/20/2005 | US20050233349 Crystal structure of ribosomal protein L11/GTPase activating region rRNA and uses thereof |
| 10/20/2005 | US20050233348 Using recombinant protein binding domains as tools for monitoring ligand binding activity in cells |
| 10/20/2005 | US20050233347 Can be used for the treatment of diabetes or for delaying the onset of diabetes |
| 10/20/2005 | US20050233346 Plant promoters and methods of use thereof |
| 10/20/2005 | US20050233341 Using single nucleotide polymorphism in fucose-1-phosphate guanylyltransferase (FPGT) and cyclin dependent kinase kinesin genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference |
| 10/20/2005 | US20050233328 Methods of identifying compounds that modulate protein activity |
| 10/20/2005 | US20050233326 Drug screening for binding property or signal transduction between a G protein-coupled receptor and humanin or a salt; Alzheimer*s disease |
| 10/20/2005 | US20050233323 Novel protein and dna thereof |
| 10/20/2005 | US20050233322 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle) |
| 10/20/2005 | US20050233321 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof |
| 10/20/2005 | US20050233316 Monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy |
| 10/20/2005 | US20050233315 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 10/20/2005 | US20050233313 Methods and reagents for identifying inhibitors of viral protease activity |
| 10/20/2005 | US20050233311 Family of picornaviruses |
| 10/20/2005 | US20050233304 Method of screening remedy for renal failure |
| 10/20/2005 | US20050233060 Protein isolated from animal muscle; filtrating acidic protein; heating; gelation |
| 10/20/2005 | US20050233003 Nanosized particles of salicylic acid wrapped in an amphiphilic polymer of polyacrylic acid, polyacrylamide, polymethacrylamide and polylysine; polymer is modified with urea, nicotinamide or guanidine |
| 10/20/2005 | US20050232950 Viruses comprising mutant ion channel protein |
| 10/20/2005 | US20050232949 transgenic edible plants comprising a nucleotide construct, including promoters that preferentially targets expression to an edible tissue of the plant and untranslated signal sequences, that codes an immunogen of a recombinant animal viral antigen protein, that induces an immune responses |
| 10/20/2005 | US20050232943 Antigenic composition of a Pseudomonas aeruginosa protein |
| 10/20/2005 | US20050232942 Virulence genes, proteins, and their use |
| 10/20/2005 | US20050232941 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 10/20/2005 | US20050232940 Recombinant plasmid and a method of controlling the effects of yersinia pestis |
| 10/20/2005 | US20050232939 Novel therapeutic compositions for treating infection by Lawsonia spp. |
| 10/20/2005 | US20050232938 Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection |
| 10/20/2005 | US20050232937 Paramycobacterial diagnostics and vaccines |
| 10/20/2005 | US20050232936 Meningococcus adhesins nada, app and orf 40 |
| 10/20/2005 | US20050232935 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 10/20/2005 | US20050232933 CMV-IE1 peptides and method of use |
| 10/20/2005 | US20050232932 Compositions and methods for dendritic cell-based immunotherapy |
| 10/20/2005 | US20050232931 Chimeric protein; induction apoptosis; anticancer agents; vaccine |
| 10/20/2005 | US20050232918 Differentially expressed genes associated with obesity and type 2 diabetes |
| 10/20/2005 | US20050232913 Short chain neurotoxin from sea snake-lapemis hardwickii and genes encoding the neurotoxin |
| 10/20/2005 | US20050232912 Enzyme phosphorylating ser46 of p53 |
| 10/20/2005 | US20050232910 Comprises sakacine G polypeptide for preventing bacterial propagation during food processing; potentially valuable for preserving fermented food products in terms of quality and health |
| 10/20/2005 | US20050232897 Mucosal cytotoxic T lymphocyte responses |
| 10/20/2005 | US20050232896 Cd137 as a proliferation factor for hematopoietic stem cells |
| 10/20/2005 | US20050232863 Identifying a compound having the ability to increase the average lifespan of a population of mice by administering a test compound having the ability to reduce Pregnancy-associated plasma protein A activity and determining if average lifespan is increased |
| 10/20/2005 | CA2590604A1 Microrna encoded by ebv, kshv and hcmv and microrna for targeting the same |
| 10/20/2005 | CA2563887A1 Mite allergen zen 1 |
| 10/20/2005 | CA2563513A1 Remedy for neurodegenerative diseases |
| 10/20/2005 | CA2563379A1 Human glp-1 mimetibodies, compositions, methods and uses |
| 10/20/2005 | CA2562969A1 Prokineticin 2beta peptide and its use |
| 10/20/2005 | CA2562385A1 Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12 |
| 10/20/2005 | CA2561947A1 Preventives/remedies for cancer |
| 10/20/2005 | CA2561809A1 Bmp-7 variants with improved properties |
| 10/20/2005 | CA2561593A1 Antiobesity drug |
| 10/20/2005 | CA2561171A1 Synthetic chemokines, methods of manufacture, and uses |
| 10/20/2005 | CA2561163A1 Stabilised tat antigen and the use thereof for anti-hiv vaccination |
| 10/20/2005 | CA2560956A1 Amphipathic glycopeptides |
| 10/20/2005 | CA2560937A1 Compositions and methods for inducing anti-tumor immunity |
| 10/20/2005 | CA2560726A1 Peptides and peptidomimetics binding to cd23 |
| 10/20/2005 | CA2560487A1 Optimized expression of hpv 52 l1 in yeast |
| 10/20/2005 | CA2559910A1 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy |
| 10/20/2005 | CA2558870A1 Process for the production of fine chemicals |
| 10/20/2005 | CA2558829A1 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 10/20/2005 | CA2558246A1 Hsv-2 type-specific immunoassays using glycoprotein g2 peptides |
| 10/19/2005 | EP1586660A1 Novel molecules of the T85-related protein family and uses thereof |
| 10/19/2005 | EP1586658A2 Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal |
| 10/19/2005 | EP1586653A1 Noc2 knockout mouse |
| 10/19/2005 | EP1586652A1 Genes and uses for plant improvement |
| 10/19/2005 | EP1586650A1 Intervention in the energy metabolism of eukaryotic cells for selection and increase of expression |
| 10/19/2005 | EP1586648A1 Juvenile hormone transmethylase genes and method of using the same |
| 10/19/2005 | EP1586646A2 Lawsonia intracellularis vaccine |
| 10/19/2005 | EP1586645A2 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| 10/19/2005 | EP1586644A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour development and for wound healing |
| 10/19/2005 | EP1586643A2 Polypeptides and nucleic acids encoding same |
| 10/19/2005 | EP1586642A2 Tumor supressor genes, proteins encoded thereby and use of said genes and proteins |